Zilei Liu

778 citations
18 papers · 613 indexed · 1 hit paper · h-index 10

Zilei Liu

18 papers receiving 609 citations

Hit Papers

SuFEx Click Chemistry Enabled Late-Stage Drug Functionali...252201820262020202350100150200250

Peers

Zilei Liu
Comparison fields: 5 of 77
  • Pharmaceutical Science 132
  • Organic Chemistry 359
  • Molecular Biology 302
  • Immunology 76
  • Radiology, Nuclear Medicine and Imaging 65
Replace Yanbo Yu with:
Yanbo Yu United States
Guoyu Zhang China
Valentina Gambini Italy
David M. Beal United Kingdom
Satoshi Osada Japan
Peter G. Slade United States
Taksim Ahmed Canada
Masataka Fumoto Japan
Hanna Hailu United Kingdom
Feng Yu China
Zilei Liu relative to Yanbo Yu United States Yanbo Yu's profile →
Citations per field
00.5×3.1×
Yanbo Yu · 1×
Citations per year

Countries citing papers authored by Zilei Liu

Since Specialization
Citations

This map shows the geographic impact of Zilei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilei Liu more than expected).

Fields of papers citing papers by Zilei Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zilei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilei Liu. The network helps show where Zilei Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zilei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zilei Liu Line = papers co-authored together Zilei Liu links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20241
2 202042
3 202094
4 20193
5 20195
6 20192
7 201858
8
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalizationbreakdown →
2018252
9 20169
10 201611
11 20163
12 201638
13 201522
14 201412
15 201429
16 20145
17 201325
18 20132

About Zilei Liu

Zilei Liu is a scholar working on Pharmaceutical Science, Endocrinology, Diabetes and Metabolism and Organic Chemistry, having authored 18 papers that have together received 613 indexed citations. Recurring topics across this work include Diet, Metabolism, and Disease (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Click Chemistry and Applications (3 papers), Chemical Synthesis and Analysis (3 papers), Fluorine in Organic Chemistry (3 papers), CAR-T cell therapy research (2 papers), Synthesis and Catalytic Reactions (2 papers) and Microbial Metabolic Engineering and Bioproduction (2 papers). The work is most often cited by research in Pharmaceutical Science (132 citations), Organic Chemistry (359 citations) and Molecular Biology (302 citations). Zilei Liu has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Peng Wu, Jie Li, Suhua Li, Gencheng Li, K. Barry Sharpless, Mingkuan Chen, George W. J. Fleet, Sarah F. Jenkinson, Yujie Shi and Wei Li. Their work appears in journals such as Cell, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026